[Risk factors and control measures in measles outbreaks in countries of the Region of the Americas, 2017-2023Fatores de risco e medidas de controle em surtos de sarampo em países da Região das Américas, 2017-2023]. [PDF]
Pastor D +5 more
europepmc +1 more source
[Successes and challenges in achieving and sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Americas, 2013-2023Conquistas e desafios para alcançar e manter a eliminação do sarampo, da rubéola e da síndrome da rubéola congênita na Região das Américas, 2013-2023]. [PDF]
Pastor D +5 more
europepmc +1 more source
[Recommendations on prevention and treatment of respiratory infections in institutionalised older people]. [PDF]
Lovatti-González R +6 more
europepmc +1 more source
No time to wait: A regional model for inter-epidemic vector-borne disease preparedness in the Caribbean. [PDF]
Dunbar W +8 more
europepmc +1 more source
History of the measles epidemics in Colombia: an incomplete count [PDF]
Amaya-Castellanos C +2 more
europepmc +1 more source
Yellow fever in Peru and the Americas and the latent risk of reurbanuzation: an avoidable threat. [PDF]
Cabezas C.
europepmc +1 more source
[Use of standardized criteria to verify interruption of a measles outbreak in the Buenos Aires Metropolitan Area during the COVID-19 pandemicEncerramento do surto de sarampo na área metropolitana de Buenos Aires durante a pandemia de COVID-19 aplicando critérios padronizados]. [PDF]
Elbert G +9 more
europepmc +1 more source
[Measles and Rubella IgG Seropositivity in the Post-elimination Era, Costa Rica, 2012-2023Soropositividade de IgG para os vírus do sarampo e da rubéola na era pós-eliminação, Costa Rica, 2012-2023]. [PDF]
Ruiz-González AI +6 more
europepmc +1 more source
[Histopathological findings associated with complete clinical remission in patients with lupus nephritis]. [PDF]
Fuentes-López EA +4 more
europepmc +1 more source
Vaccines, equity and sovereignty: Science for the world from Colombia [PDF]
Muñoz-Durango N +2 more
europepmc +1 more source

